Clinical Trials on Age- Related Macular Degeneration in Germany
Total 376 results
-
Apheresis Research InstituteCompletedDry Age Related Macular DegenerationGermany
-
University of LuebeckCompletedAge-Related Macular Degeneration | Retinal FunctionGermany
-
University of JenaCompleted
-
Johann Wolfgang Goethe University HospitalCompletedAge-Related Macular DegenerationGermany
-
BayerRegeneron PharmaceuticalsCompletedWet Age-related Macular DegenerationGermany
-
National Eye Institute (NEI)Completed
-
Johannes Gutenberg University MainzNovartisCompletedNeovascular Age-related Macular DegenerationGermany
-
Novartis PharmaceuticalsCompleted
-
University of LuebeckCompletedAge-Related Macular DegenerationGermany
-
Klinikum Chemnitz gGmbHCompletedAge Related Macular Degeneration | Epiretinal Membrane | Macular HolesGermany
-
Novartis PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationSpain, Italy, Germany, Canada, Ireland
-
Newtricious R&D BVSprim Advanced Life SciencesCompletedAge-related Macular Degeneration (AMD)United States, Germany, Netherlands, United Kingdom
-
University Hospital, BonnCompletedAge Related Macular DegenerationGermany
-
University of JenaCompletedAge Related MaculopathyGermany
-
LumiThera, Inc.CompletedDry Age-related Macular DegenerationUnited Kingdom, Spain, France, Germany, Italy
-
University Hospital, BonnCompletedNonexudative Age-related Macular DegenerationGermany
-
VisionCare, Inc.RecruitingAge-Related Macular Degeneration | AMDItaly, Ireland, Spain, Germany, United Kingdom
-
Frank G. HolzRadboud University Medical Center; Bayer; Hoffmann-La Roche; Novartis Pharmaceuticals and other collaboratorsActive, not recruitingAge Related Macular Degeneration (AMD)Germany, Italy, Netherlands, United Kingdom, France, Portugal, Denmark
-
Klinikum LudwigshafenPfizerUnknownAge-related Macular DegenerationGermany
-
BayerRecruitingVisual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
-
University Hospital TuebingenCompletedStress | Age-related Macular DegenerationGermany
-
Klinikum Bremen-Mitte, gGmbHKompetenzzentrum für Klinische Studien, BremenUnknownAge-Related Neovascular Macular DegenerationGermany
-
Hoffmann-La RocheRecruitingNeovascular Age-related Macular Degeneration (nAMD)Belgium, Korea, Republic of, Germany, Spain, United Kingdom, Australia, Italy, Argentina, Israel, Austria, Brazil, France, Singapore, Switzerland, Taiwan, Turkey
-
Hoffmann-La RocheRecruitingNeovascular Age-Related Macular DegenerationBelgium, United States, United Kingdom, Italy, Argentina, Spain, Israel, Australia, Austria, Brazil, Germany, Switzerland, Taiwan, France
-
University of RegensburgDr. Werner Jackstaedt FoundationUnknownAge-Related Macular Degeneration | Central Serous Chorioretinopathy | Diabetic MaculopathyGermany
-
Novartis PharmaceuticalsCompletedAge-related Macular DegenerationGermany, Switzerland
-
University Hospital MuensterUnknown
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Austria, Belgium, Denmark, Switzerland, France, Netherlands, Portugal, Sweden, Norway
-
Bioeq GmbHCompletedAge-related Macular Degeneration (AMD)France, Italy, Poland, Russian Federation, Spain, United Kingdom, Germany, Hungary, Ukraine, Austria, Czechia, Israel
-
OccuLogixSuspendedAge-Related MaculopathyUnited States, Germany, Canada
-
Samsung Bioepis Co., Ltd.CompletedAge-Related Macular DegenerationKorea, Republic of, United States, India, Germany, Hungary, United Kingdom, Czechia, Poland, Russian Federation
-
Shanghai Henlius BiotechActive, not recruitingA Phase 3 Study to Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMDAge Related Macular DegenerationUnited States, Singapore, Spain, Germany, Slovakia, China, Hungary, Australia, Bulgaria, Poland, Latvia, Czechia, France, Italy, Serbia
-
ThromboGenicsCompletedExudative Age-Related Macular Degeneration | Focal Vitreomacular AdhesionUnited States, United Kingdom, Germany, France, Belgium, Italy
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Turkey, Austria, Canada, Czechia, United Kingdom, Hungary, Italy, Lithuania, Guatemala, France, Ireland, Argentina, Portugal, Spain, Sweden, Greece, Switzerland, Slovakia, Finland, Netherlands, Colombia, Mexico, Panama
-
SandozCompletedNeovascular Age-related Macular DegenerationUnited States, Bulgaria, Czechia, Australia, Austria, France, Germany, Hungary, Israel, Japan, Latvia, Lithuania, Poland, Portugal, Slovakia, Spain
-
Opthea LimitedRecruitingNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Czechia, Denmark, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Latvia, Malaysia, Poland, Spain, Thailand, Ukraine, United Kingdom
-
Opthea LimitedActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Brazil, Bulgaria, Canada, Colombia, Croatia, Czechia, Denmark, Estonia, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Philippines and more
-
Hoffmann-La RocheActive, not recruitingNeovascular Age-related Macular DegenerationUnited States, Korea, Republic of, United Kingdom, Japan, Canada, Turkey, Argentina, Australia, Denmark, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Brazil, Hong Kong, Israel, Portugal, Russian Federation, Ta... and more
-
Chengdu Kanghong Biotech Co., Ltd.TerminatedNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Germany, Hong Kong, Lithuania, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Portugal, Singapore, Spain, Switzerland, Taiwan
-
Genentech, Inc.RecruitingAge-Related Macular DegenerationFrance, Germany, Israel, United States, Australia, Puerto Rico, Italy
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationUnited States, Czechia, Italy, Taiwan, Australia, Israel, Belgium, France, Spain, Germany, Korea, Republic of, Portugal, Sweden, Netherlands, Malaysia, Switzerland
-
University Hospital, BonnCompletedAge-related Macular DegenerationGermany
-
AmgenParexelCompletedNeovascular (Wet) Age-related Macular Degeneration (AMD)Spain, United States, Czechia, Serbia, Israel, Canada, Germany, Japan, Hungary, Poland, Korea, Republic of, Estonia, Hong Kong, Italy, Latvia, Lithuania, Mexico, Slovakia
-
Ophthotech CorporationTerminatedAge-Related Macular DegenerationIsrael, United States, Germany, Denmark, France, Turkey, Hungary, Colombia, Australia, Argentina, Spain
-
AllerganCompletedAge-related Macular DegenerationUnited States, Italy, Australia, Israel, Germany, Austria, France, Switzerland
-
Ophthotech CorporationTerminatedAge-Related Macular DegenerationFrance, Israel, Italy, United States, Spain, Portugal, Germany, Austria, Canada, Czechia, Estonia, Latvia, Poland, Slovakia, Australia, Hungary, Croatia, Argentina, Finland, Brazil, Colombia, Norway
-
Novartis PharmaceuticalsActive, not recruitingDiabetic Macular Edema (DME) | Neovascular Age-related Macular Degeneration (nAMD)Germany
-
Oraya Therapeutics, Inc.CompletedEye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Retinal Diseases | AMD | Wet AMD | Wet Age-Related Macular DegenerationUnited Kingdom, Czech Republic, Austria, Germany, Italy
-
Association for Innovation and Biomedical Research...European Vision Institute Clinical Research NetworkActive, not recruitingAtrophy | Age Related Macular Degeneration | Prediction | Intermediate AMDPortugal, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
Alkahest, Inc.CompletedNeovascular Age-related Macular DegenerationUnited States, Germany, Poland, Hungary